Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T19:17:48.659Z.
Calculation as of: 2026-10-06T19:17:48.659Z.
Quote observation: 2026-10-06T19:15:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bddae1a009f0b40e7fb659cb125a310776fd64778f9839bff19075a224db575c
PE RATIO
N/A
Market Cap
$169.21M
PE Ratio
N/A
TTM Avg
22.05
3Y Avg
43.38
5Y Avg
28.58
Market Cap
$170.94M
PE Ratio
N/A
TTM Avg
11.57
3Y Avg
11.57
5Y Avg
11.57
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $166.34M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.47M | 37.75 | 23.37 | 23.37 | 443.72 |
| Quanterix Corporation (QTRX)vs › | $162.80M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $169.59M | N/A | 7.76 | 7.76 | 7.76 |
| Cue Biopharma, Inc. (CUE)vs › | $169.55M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $162.23M | N/A | 5.36 | 5.36 | 8.25 |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.21M | N/A | 22.05 | 43.38 | 28.58 |
| Precision BioSciences, Inc. (DTIL)vs › | $170.94M | N/A | 11.57 | 11.57 | 11.57 |
| PepGen Inc. (PEPG)vs › | $160.13M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.02M | N/A | 4.03 | 4.03 | 14.59 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$2.33
Forward EPS (Est.)
$-1.67
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
